These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21537356)

  • 1. White matter disease: Roles of anti-MOG antibodies in demyelinating diseases.
    Olsson T
    Nat Rev Neurol; 2011 May; 7(5):248-9. PubMed ID: 21537356
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents.
    Breithaupt C; Schäfer B; Pellkofer H; Huber R; Linington C; Jacob U
    J Immunol; 2008 Jul; 181(2):1255-63. PubMed ID: 18606679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.
    von Büdingen HC; Tanuma N; Villoslada P; Ouallet JC; Hauser SL; Genain CP
    J Clin Immunol; 2001 May; 21(3):155-70. PubMed ID: 11403222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report.
    Zhang H; Yang Y; Luo X
    J Neuroimmunol; 2021 Apr; 353():577519. PubMed ID: 33631487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein.
    O'Connor KC; Appel H; Bregoli L; Call ME; Catz I; Chan JA; Moore NH; Warren KG; Wong SJ; Hafler DA; Wucherpfennig KW
    J Immunol; 2005 Aug; 175(3):1974-82. PubMed ID: 16034142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
    Armangue T; Capobianco M; de Chalus A; Laetitia G; Deiva K;
    Eur J Paediatr Neurol; 2020 Nov; 29():22-31. PubMed ID: 33191096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelitis with normal spinal cord MRI: don't forget anti-MOG antibodies disease!
    Grangeon L; Hébant B; Guillaume M; Ahtoy P; Lefaucheur R
    Acta Neurol Belg; 2020 Aug; 120(4):945-946. PubMed ID: 32157671
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoantibodies in inflammatory demyelinating diseases of the central nervous system.
    Lalive PH
    Swiss Med Wkly; 2008 Nov; 138(47-48):692-707. PubMed ID: 18951202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?
    Breza M; Koutsis G; Tzartos JS; Velonakis G; Evangelopoulos ME; Tzanetakos D; Karagiorgou K; Angelopoulou G; Kasselimis D; Potagas C; Anagnostouli M; Stefanis L; Kilidireas C
    Mult Scler Relat Disord; 2019 Aug; 33():67-69. PubMed ID: 31158804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated area postrema syndrome with anti-MOG antibodies, a rare association].
    Paviolo JP; Tkachuk VA
    Rev Neurol; 2020 Aug; 71(3):125-126. PubMed ID: 32672352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent visual loss in a 64-year-old man.
    Murphy OC; Newsome SD
    Pract Neurol; 2020 Apr; 20(2):175-178. PubMed ID: 31649102
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to MOG in CSF only: pathological findings support the diagnostic value.
    Carta S; Höftberger R; Bolzan A; Bozzetti S; Bonetti B; Scarpelli M; Ottaviani S; Ghimenton C; Alberti D; Schanda K; Reindl M; Marignier R; Ferrari S; Mariotto S
    Acta Neuropathol; 2021 May; 141(5):801-804. PubMed ID: 33609159
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
    Reder AT; Oger JJ
    Neurology; 2004 Jun; 62(11):1922-3. PubMed ID: 15184588
    [No Abstract]   [Full Text] [Related]  

  • 15. The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Stefferl A; Brehm U; Linington C
    J Neural Transm Suppl; 2000; (58):123-33. PubMed ID: 11128602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.
    Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C
    Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific immunotherapy for MOG antibody-associated diseases.
    Nessler S
    EBioMedicine; 2019 Oct; 48():18-19. PubMed ID: 31590929
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS.
    Komatsu T; Matsushima S; Kaneko K; Fukuda T
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):111-112. PubMed ID: 30297517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.